160 related articles for article (PubMed ID: 33559150)
1. Soluble epoxide hydrolase inhibitor trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl)urea prevents hyperalgesia through regulating NLRC4 inflammasome-related pro-inflammatory and anti-inflammatory signaling pathways in the lipopolysaccharide-induced pain mouse model.
Cagli A; Senol SP; Temiz-Resitoglu M; Guden DS; Sari AN; Sahan-Firat S; Tunctan B
Drug Dev Res; 2021 Sep; 82(6):815-825. PubMed ID: 33559150
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of NLRP3 Inflammasome Prevents LPS-Induced Inflammatory Hyperalgesia in Mice: Contribution of NF-κB, Caspase-1/11, ASC, NOX, and NOS Isoforms.
Dolunay A; Senol SP; Temiz-Resitoglu M; Guden DS; Sari AN; Sahan-Firat S; Tunctan B
Inflammation; 2017 Apr; 40(2):366-386. PubMed ID: 27924425
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological inhibition of soluble epoxide hydrolase attenuates chronic experimental autoimmune encephalomyelitis by modulating inflammatory and anti-inflammatory pathways in an inflammasome-dependent and -independent manner.
Biliktu M; Senol SP; Temiz-Resitoglu M; Guden DS; Horat MF; Sahan-Firat S; Sevim S; Tunctan B
Inflammopharmacology; 2020 Dec; 28(6):1509-1524. PubMed ID: 32128702
[TBL] [Abstract][Full Text] [Related]
4. Epoxyeicosatrienoic acids inhibit the activation of NLRP3 inflammasome in murine macrophages.
Luo XQ; Duan JX; Yang HH; Zhang CY; Sun CC; Guan XX; Xiong JB; Zu C; Tao JH; Zhou Y; Guan CX
J Cell Physiol; 2020 Dec; 235(12):9910-9921. PubMed ID: 32452554
[TBL] [Abstract][Full Text] [Related]
5. Soluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3- (1-propionylpiperidin-4-yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice.
Zhou Y; Yang J; Sun GY; Liu T; Duan JX; Zhou HF; Lee KS; Hammock BD; Fang X; Jiang JX; Guan CX
Cell Tissue Res; 2016 Feb; 363(2):399-409. PubMed ID: 26310139
[TBL] [Abstract][Full Text] [Related]
6. Contribution of iNOS/sGC/PKG pathway, COX-2, CYP4A1, and gp91(phox) to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against vasodilation, hypotension, tachycardia, and inflammation in a rat model of septic shock.
Tunctan B; Korkmaz B; Sari AN; Kacan M; Unsal D; Serin MS; Buharalioglu CK; Sahan-Firat S; Cuez T; Schunck WH; Manthati VL; Falck JR; Malik KU
Nitric Oxide; 2013 Sep; 33():18-41. PubMed ID: 23684565
[TBL] [Abstract][Full Text] [Related]
7. Soluble Epoxide Hydrolase Inhibitor Attenuates Lipopolysaccharide-Induced Acute Lung Injury and Improves Survival in Mice.
Zhou Y; Liu T; Duan JX; Li P; Sun GY; Liu YP; Zhang J; Dong L; Lee KSS; Hammock BD; Jiang JX; Guan CX
Shock; 2017 May; 47(5):638-645. PubMed ID: 27753791
[TBL] [Abstract][Full Text] [Related]
8. Soluble Epoxide Hydrolase Inhibitor Suppresses the Expression of Triggering Receptor Expressed on Myeloid Cells-1 by Inhibiting NF-kB Activation in Murine Macrophage.
Dong L; Zhou Y; Zhu ZQ; Liu T; Duan JX; Zhang J; Li P; Hammcok BD; Guan CX
Inflammation; 2017 Feb; 40(1):13-20. PubMed ID: 27696333
[TBL] [Abstract][Full Text] [Related]
9. Peripheral NLCR4 inflammasome participates in the genesis of acute inflammatory pain.
Lopes AH; Talbot J; Silva RL; Lima JB; França RO; Verri WA; Mascarenhas DP; Ryffel B; Cunha FQ; Zamboni DS; Cunha TM
Pain; 2015 Mar; 156(3):451-459. PubMed ID: 25687541
[TBL] [Abstract][Full Text] [Related]
10. 1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea, a Selective and Potent Dual Inhibitor of Soluble Epoxide Hydrolase and p38 Kinase Intervenes in Alzheimer's Signaling in Human Nerve Cells.
Liang Z; Zhang B; Xu M; Morisseau C; Hwang SH; Hammock BD; Li QX
ACS Chem Neurosci; 2019 Sep; 10(9):4018-4030. PubMed ID: 31378059
[TBL] [Abstract][Full Text] [Related]
11. Soluble epoxide hydrolase inhibition avoid formalin-induced inflammatory hyperalgesia in the temporomandibular joint.
Abdalla HB; Napimoga MH; Teixeira JM; Trindade-da-Silva CA; Pieroni VL; Dos Santos Araújo FSM; Hammock BD; Clemente-Napimoga JT
Inflammopharmacology; 2022 Jun; 30(3):981-990. PubMed ID: 35303234
[TBL] [Abstract][Full Text] [Related]
12. Suppression of TLR4/MyD88/TAK1/NF-κB/COX-2 Signaling Pathway in the Central Nervous System by Bexarotene, a Selective RXR Agonist, Prevents Hyperalgesia in the Lipopolysaccharide-Induced Pain Mouse Model.
Senol SP; Temiz-Resitoglu M; Guden DS; Sari AN; Sahan-Firat S; Tunctan B
Neurochem Res; 2021 Mar; 46(3):624-637. PubMed ID: 33389386
[TBL] [Abstract][Full Text] [Related]
13. Peripheral soluble epoxide hydrolase inhibition reduces hypernociception and inflammation in albumin-induced arthritis in temporomandibular joint of rats.
Teixeira JM; Abdalla HB; Basting RT; Hammock BD; Napimoga MH; Clemente-Napimoga JT
Int Immunopharmacol; 2020 Oct; 87():106841. PubMed ID: 32736189
[TBL] [Abstract][Full Text] [Related]
14. Soluble Epoxide Hydrolase Pharmacological Inhibition Decreases Alveolar Bone Loss by Modulating Host Inflammatory Response, RANK-Related Signaling, Endoplasmic Reticulum Stress, and Apoptosis.
Trindade-da-Silva CA; Bettaieb A; Napimoga MH; Lee KSS; Inceoglu B; Ueira-Vieira C; Bruun D; Goswami SK; Haj FG; Hammock BD
J Pharmacol Exp Ther; 2017 Jun; 361(3):408-416. PubMed ID: 28356494
[TBL] [Abstract][Full Text] [Related]
15. A Soluble Epoxide Hydrolase Inhibitor, 1-TrifluoromethoxyPhenyl-3-(1-Propionylpiperidin-4-yl) Urea, Ameliorates Experimental Autoimmune Encephalomyelitis.
Jonnalagadda D; Wan D; Chun J; Hammock BD; Kihara Y
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925035
[TBL] [Abstract][Full Text] [Related]
16. NLRC3 protein inhibits inflammation by disrupting NALP3 inflammasome assembly via competition with the adaptor protein ASC for pro-caspase-1 binding.
Eren E; Berber M; Özören N
J Biol Chem; 2017 Jul; 292(30):12691-12701. PubMed ID: 28584053
[TBL] [Abstract][Full Text] [Related]
17. Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption.
Napimoga MH; Rocha EP; Trindade-da-Silva CA; Demasi APD; Martinez EF; Macedo CG; Abdalla HB; Bettaieb A; Haj FG; Clemente-Napimoga JT; Inceoglu B; Hammock BD
J Periodontal Res; 2018 Oct; 53(5):743-749. PubMed ID: 29851077
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of soluble epoxide hydrolase alleviates insulin resistance and hypertension via downregulation of SGLT2 in the mouse kidney.
Luo J; Hu S; Fu M; Luo L; Li Y; Li W; Cai Y; Dong R; Yang Y; Tu L; Xu X
J Biol Chem; 2021; 296():100667. PubMed ID: 33864813
[TBL] [Abstract][Full Text] [Related]
19. Omeprazole increases the efficacy of a soluble epoxide hydrolase inhibitor in a PGE₂ induced pain model.
Goswami SK; Inceoglu B; Yang J; Wan D; Kodani SD; da Silva CA; Morisseau C; Hammock BD
Toxicol Appl Pharmacol; 2015 Dec; 289(3):419-27. PubMed ID: 26522832
[TBL] [Abstract][Full Text] [Related]
20. Pro-inflammatory GPR75 and anti-apoptotic phospholipase signaling pathways contribute to the ameliorating effect of soluble epoxide hydrolase inhibition on chronic experimental autoimmune encephalomyelitis in mice.
Horat MF; Senol SP; Bahceli O; Temiz-Resitoglu M; Sahan-Firat S; Sevim S; Tunctan B
Cell Mol Biol (Noisy-le-grand); 2023 Oct; 69(10):9-16. PubMed ID: 37953590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
